News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Thompson Peter A.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/28/2023 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.5, valued at
$260k
|
|
| 01/05/2023 |
4
| Thompson Peter A. (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Granted 10,000 options to buy
@ $0 |
|
| 09/16/2022 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Bought 484,496 shares
@ $10.32, valued at
$5M
|
|
| 08/15/2022 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.965, valued at
$14.5k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Decibel Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.3, valued at
$23k
|
|
| 06/17/2022 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.9899, valued at
$14.8k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Silverback Therapeutics, Inc.|
Txns:
| Granted 18,000 options to buy
@ $4.18, valued at
$75.2k
|
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2022 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Granted 10,000 options to buy
@ $0 |
|
| 12/30/2021 |
4
| Thompson Peter A. (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Sold 36,700 shares
@ $20.3, valued at
$745k
Sold 3,700 shares
@ $20.3, valued at
$75.1k
|
|
| 12/23/2021 |
4
| Thompson Peter A. (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Sold 108,300 shares
@ $19, valued at
$2.1M
Sold 11,100 shares
@ $19, valued at
$210.9k
|
|
| 12/17/2021 |
4
| Thompson Peter A. (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Sold 356,800 shares
@ $19.07, valued at
$6.8M
Sold 36,500 shares
@ $19.07, valued at
$696.1k
|
|
| 09/22/2021 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Sold 1,109,644 shares
@ $6.09, valued at
$6.8M
|
|
| 09/21/2021 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Bought 585,106 shares
@ $9.4, valued at
$5.5M
Bought 425,531 shares
@ $9.4, valued at
$4M
|
|
| 09/21/2021 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Silverback Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $28.83, valued at
$432.5k
|
|
| 09/13/2021 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.6, valued at
$39k
|
|
| 06/16/2021 |
4
| Thompson Peter A. (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Converted 1,348,421 shares
@ $0
Converted 823,742 shares
@ $0
Bought 588,203 shares
@ $17, valued at
$10M
Converted 164,748 shares
@ $0
Bought 117,650 shares
@ $17, valued at
$2M
Converted 1,052,632 convertible preferred
@ $0
Converted 643,046 convertible preferred
@ $0
Converted 128,609 convertible preferred
@ $0 |
|
| 06/16/2021 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.74, valued at
$41.1k
|
|
| 06/14/2021 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $17, valued at
$510k
|
|
| 06/10/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2021 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Converted 12,730,036 shares
@ $0
Converted 272,724 shares
@ $0
Bought 46,875 shares
@ $16, valued at
$750k
Bought 312,500 shares
@ $16, valued at
$5M
Converted 8,187,100 preferred shares
@ $0
Converted 1,572,960 preferred shares
@ $0
Converted 1,301,626 preferred shares
@ $0
Converted 1,668,350 preferred shares
@ $0
Converted 272,724 preferred shares
@ $0 |
|
| 03/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/19/2021 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Decibel Therapeutics, Inc.|
Txns:
| Converted 2,732,106 shares
@ $0
Converted 327,852 shares
@ $0
Converted 218,568 shares
@ $0
Bought 1,111,100 shares
@ $18, valued at
$20M
Bought 555,566 shares
@ $18, valued at
$10M
Converted 14,480,162 preferred shares
@ $0
Converted 1,737,619 preferred shares
@ $0
Converted 1,158,412 preferred shares
@ $0 |
|
| 02/19/2021 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 1,285,714 shares
@ $3.5, valued at
$4.5M
|
|
| 02/16/2021 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Decibel Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $18, valued at
$360k
|
|
| 02/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/26/2021 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Prevail Therapeutics Inc.|
Txns:
| Unknown transaction of 13,822,463 shares
@ $0
Disposed/sold 17,000 options to buy
@ $16.98, valued at
$288.7k
|
|
| 01/05/2021 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Granted 7,650 options to buy
@ $0 |
|
| 12/30/2020 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Sold 600,000 shares
@ $14.25, valued at
$8.6M
|
|
| 12/08/2020 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Silverback Therapeutics, Inc.|
Txns:
| Bought 238,100 shares
@ $21, valued at
$5M
Converted 3,462,737 shares
@ $0
Converted 2,493,741 shares
@ $0
Converted 1,055,287 shares
@ $0
Bought 952,377 shares
@ $21, valued at
$20M
Converted 12,857,142 preferred shares
@ $0
Converted 9,259,259 preferred shares
@ $0
Converted 3,918,279 preferred shares
@ $0 |
|
| 12/07/2020 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on Silverback Therapeutics, Inc.|
Txns:
| Granted 38,270 options to buy
@ $21, valued at
$803.7k
|
|
|
|
|